Alan G. White

3.3k total citations · 3 hit papers
74 papers, 2.1k citations indexed

About

Alan G. White is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Epidemiology. According to data from OpenAlex, Alan G. White has authored 74 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Public Health, Environmental and Occupational Health, 18 papers in Pharmacology and 12 papers in Epidemiology. Recurrent topics in Alan G. White's work include Opioid Use Disorder Treatment (22 papers), Pain Management and Opioid Use (9 papers) and Musculoskeletal pain and rehabilitation (9 papers). Alan G. White is often cited by papers focused on Opioid Use Disorder Treatment (22 papers), Pain Management and Opioid Use (9 papers) and Musculoskeletal pain and rehabilitation (9 papers). Alan G. White collaborates with scholars based in United States, United Kingdom and Australia. Alan G. White's co-authors include Howard G. Birnbaum, M. Schiller, J. Bradford Rice, Carl L. Roland, Jody M. Cleveland, Tracy Waldman, Winnie W. Nelson, Nathaniel P. Katz, George J. Wan and Lauren M. Scarpati and has published in prestigious journals such as Journal of Bacteriology, Pain and Annals of the Rheumatic Diseases.

In The Last Decade

Alan G. White

72 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States

2011 506 citations Howard G. Birnbaum, Alan G. White et al. Pain Medicine profile →
Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review

2017 335 citations J. Bradford Rice, Alan G. White et al. Clinical Therapeutics profile →
The world's first anabolic‐androgenic steroid testing trial: A two‐phase pilot combining chemical analysis, results dissemination and community feedback

2025 15 citations Timothy Piatkowski, Ross Coomber et al. Addiction profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan G. White United States	19	1.1k	596	437	340	287	74	2.1k
Ashish V. Joshi United States	28	388 0.4×	453 0.8×	117 0.3×	201 0.6×	172 0.6×	103	2.5k
Stephen Rice United Kingdom	23	203 0.2×	297 0.5×	274 0.6×	203 0.6×	180 0.6×	75	2.3k
Samuel M. Lesko United States	28	442 0.4×	286 0.5×	82 0.2×	393 1.2×	187 0.7×	46	2.7k
Doreen Matsui Canada	29	1.0k 1.0×	257 0.4×	61 0.1×	1.0k 2.9×	115 0.4×	87	3.0k
Alipasha Meysamie Iran	32	579 0.5×	626 1.1×	72 0.2×	193 0.6×	78 0.3×	130	3.4k
Lauren E. Kelly Canada	20	361 0.3×	591 1.0×	213 0.5×	637 1.9×	176 0.6×	83	2.1k
David B. Hanna United States	29	186 0.2×	771 1.3×	180 0.4×	93 0.3×	144 0.5×	128	3.1k
Alan C. Fisher United States	26	833 0.8×	367 0.6×	34 0.1×	336 1.0×	169 0.6×	56	2.1k
Ami Claxton United States	16	257 0.2×	513 0.9×	43 0.1×	377 1.1×	392 1.4×	28	3.2k
Juhani Tuominen Finland	26	477 0.4×	249 0.4×	59 0.1×	272 0.8×	75 0.3×	59	2.2k

Countries citing papers authored by Alan G. White

Since Specialization

Citations

This map shows the geographic impact of Alan G. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan G. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan G. White more than expected).

Fields of papers citing papers by Alan G. White

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan G. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan G. White. The network helps show where Alan G. White may publish in the future.

Co-authorship network of co-authors of Alan G. White

This figure shows the co-authorship network connecting the top 25 collaborators of Alan G. White. A scholar is included among the top collaborators of Alan G. White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan G. White. Alan G. White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Piatkowski, Timothy, Ross Coomber, Sarah L. Cresswell, et al.. (2025). The world's first anabolic‐androgenic steroid testing trial: A two‐phase pilot combining chemical analysis, results dissemination and community feedback. Addiction. 120(7). 1366–1377. 15 indexed citations breakdown →

Piatkowski, Timothy, R. Brien, Ross Coomber, et al.. (2025). Development, dissemination and community response towards the first community notice regarding misrepresented illicit anabolic‐androgenic steroids in circulation in Australia. Drug and Alcohol Review. 44(3). 735–741. 3 indexed citations

Piatkowski, Timothy, Ross Coomber, Sarah L. Cresswell, et al.. (2025). Anabolic-androgenic steroid testing as a tool for consumer engagement and harm reduction: a sequential explanatory mixed-method study. Harm Reduction Journal. 22(1). 114–114. 4 indexed citations

Silverman, Stuart L., et al.. (2022). Risk Factors Associated with Falls and Fractures Following Prescription of Opioids Among Privately Insured Patients with Osteoarthritis. Journal of health economics and outcomes research. 9(2). 47–56. 2 indexed citations

Silverman, Stuart L., et al.. (2022). All-Cause Health Care and Work Loss Burden Associated With Nonsteroidal Anti-Inflammatory Drug and Opioid Treatment in Employed Patients With Osteoarthritis. Journal of Occupational and Environmental Medicine. 64(8). 699–706. 2 indexed citations

White, Alan G., et al.. (2020). Direct Costs of Opioid Abuse in an Insured Population in the United States. Journal of Managed Care & Specialty Pharmacy. 26(10). 1188–1198. 25 indexed citations

White, Alan G., et al.. (2019). Assessment of Work Loss Associated With Prescription-Related Opioid Use Disorder. Journal of Occupational and Environmental Medicine. 62(3). 217–222. 4 indexed citations

White, Alan G., Louis P. Garrison, Gary M. Oderda, et al.. (2017). Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients. Journal of Opioid Management. 13(5). 291–301. 3 indexed citations

Rice, J. Bradford, Alan G. White, Lauren M. Scarpati, George J. Wan, & Winnie W. Nelson. (2017). Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review. Clinical Therapeutics. 39(11). 2216–2229. 335 indexed citations breakdown →

10.

White, Alan G., et al.. (2016). (263) A model to quantify potential medical events avoided and cost savings from abuse deterrent opioids. Journal of Pain. 17(4). S41–S41. 1 indexed citations

11.

Kirson, Noam Y., Amie Shei, Alan G. White, et al.. (2014). Societal Economic Benefits Associated with an Extended-Release Opioid with Abuse-Deterrent Technology in the United States. Pain Medicine. 15(9). 1450–1454. 12 indexed citations

12.

White, Alan G., et al.. (2011). Economic Impact of Opioid Abuse, Dependence, and Misuse. The American Journal of Managed Care. 3. 27 indexed citations

13.

Birnbaum, Howard G., Alan G. White, M. Schiller, et al.. (2011). Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States. Pain Medicine. 12(4). 657–667. 506 indexed citations breakdown →

14.

Kirson, Noam Y., Alan G. White, Howard G. Birnbaum, et al.. (2011). Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HCl. Journal of Medical Economics. 15(1). 87–95. 2 indexed citations

15.

Birnbaum, Howard G., Alan G. White, Jennifer L. Reynolds, et al.. (2006). Estimated Costs of Prescription Opioid Analgesic Abuse in the United States in 2001. Clinical Journal of Pain. 22(8). 667–676. 114 indexed citations

16.

White, Alan G., et al.. (2005). Economic Burden of Illness for Employees with Painful Conditions. Journal of Occupational and Environmental Medicine. 47(9). 884–892. 30 indexed citations

17.

White, Alan G., Howard G. Birnbaum, Milena N. Mareva, et al.. (2005). Direct Costs of Opioid Abuse in an Insured Population in the United States. Journal of Managed Care Pharmacy. 11(6). 469–479. 165 indexed citations

18.

Harper, Ian, et al.. (1996). Tuberculosis case finding in remote mountainous areas - Are microscopy camps of any value? Experience from Nepal. Tubercle and Lung Disease. 77(4). 384–388. 11 indexed citations

19.

Lewi, Henry, et al.. (1987). Fused vesical calculi. Urology. 30(3). 267–268. 4 indexed citations

20.

White, Alan G.. (1977). Nosocomial gram-negative infections.. PubMed. 70(8). 649–52. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact